Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Elevation Oncology Inc’s current trading price is -92.15% away from its 52-week high, while its distance from the 52-week low is 53.85%. The stock’s price range during this period has varied between $0.22 and $4.33. The company, active in the Healthcare sector, saw a trading volume of around 2.58 million for the day, considerably higher average daily volume of 1.41 million observed over the last three months.
Elevation Oncology Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $4.33 on 05/31/24, while the lowest price during the same period was $0.22 on 04/09/25.
How Financial Performance Impacts Market Capitalization
Elevation Oncology Inc (ELEV) has experienced a quarterly decline of -49.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.14M and boasts a workforce of 34 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4867, with a change in price of -0.2400. Similarly, Elevation Oncology Inc recorded 2,003,017 in trading volume during the last 100 days, posting a change of -41.38%.
How ELEV’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ELEV stands at 0.67. Similarly, the long-term debt-to-equity ratio is also 0.67.
ELEV Stock Stochastic Average
As of today, the raw stochastic average of Elevation Oncology Inc over the last 50 days is at 36.62%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 55.03%. Further, the company’s Stochastic %K and %D values for the last 20 days were 28.58% and 30.87%, respectively.
ELEV Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -39.57%.However, over the last six months, we can see a stronger performance of -45.02%. Over the last 30 days, the price of ELEV has leaped by -11.92%. And in the last five days, it has fallen by -5.63%.
